Clinical Trials Directory

Trials / Unknown

UnknownNCT02868775

A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome

A Pilot Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Philadelphia Urosurgical Associates · Academic / Other
Sex
Female
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This is a prospective pilot study, with a recruitment goal of 60 patients. Patients who are female, above the age of 18, and with a diagnosis of IC/BPS based on clinical criteria and O'Leary Sant ICPI and ICSI scores undergoing cystoscopy, hydrodistention and bladder biopsy will be included. The bladder biopsies will be evaluated for TLR4 expression, and sent for histological assessment of mast cell count. Additionally, data will be collected at baseline, day of surgery, day 7, day 14 and day 28. Data will include validated questionnaires, lower urinary tract symptoms, and recorded pain medication use.

Conditions

Interventions

TypeNameDescription
PROCEDUREcystoscopy, bladder hydrodistention and bladder biopsy

Timeline

Start date
2016-09-01
Primary completion
2017-06-01
Completion
2017-10-01
First posted
2016-08-16
Last updated
2017-01-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02868775. Inclusion in this directory is not an endorsement.

A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syn (NCT02868775) · Clinical Trials Directory